BNET Industries

BioMS Medical Corp.

MS is in the Pharma Industry

Market Cap:$43.6B
Last Fiscal Year Sales:$47.5M
  • Public
  • CA
Dow Jones Description

BioMS Medical is a Canadian biotech company engaged in the development and commercialization of novel therapeutic technologies with emphasis on the treatment of Multiple Sclerosis (MS). BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The technology, dirucotide (MBP8298), is a synthetic myelin basic protein peptide comprised of 17 amino acids which is intravenously injected (every six months) into MS patients as a therapeutic treatment. BioMS is currently conducting three late-stage clinical trials and one open-label trial for dirucotide (MBP8298):

Number of Employees 25
Contact Information

6030 88th Street

Edmonton, Alberta T6E 6G4

www.biomsmedica...

(780) 413-7152

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • BioMS Medical Announces Third Quarter 2009 Results

    11/12/09 - Financial Announcement - View Story

  • BioMS Medical terminates exclusive licensing agreement with Eli Lilly for dirucotide

    9/07/09 - Joint Venture / Alliance - View Story

  • BioMS Medical announces second quarter 2009 results

    7/18/09 - Financial Announcement - View Story

News & Analysis

bioms medical corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Kevin Giese CEO
Don Kimak CFO
Kjell Stenberg COO
Tony Hesby Executive Vice President Corporate Affairs
Leopold Arfors Vice President, Clinical Affairs
Les Ferenczi Vice President, Biostatistics
Mark Krantz Vice President, Scientific Affairs
Randy Stroud Vice President, Regulatory Affairs
Richard Brown Vice President, Commercial Dev
Ryan Giese Vice President, Corp Comm
Tony Verco Vice President, Drug Dev
Laine M. Woollard Lead Director
Amanda Stadel Manager
Hans-Peter Hartung Bioms Announces Professor
Len Wiebe
Linda Pilarski
Michael Kennedy Secretary
Laine Wollard Director

Board of Directors

Name (plus bio) Position
Cliff Giese Chairman of the Board
Carolyn Young Board of Directors
Clyde Markowitz Board of Directors
Gordon J Politeski Board of Directors
Ingrid Catz Board of Directors
John R Wetherell Board of Directors
Ken Warren Board of Directors
Mark Freedman Board of Directors
Tomas Olsson Board of Directors
William D. Grace Board of Directors

Kevin Giese, who has earned a B.A. in economics, a law degree, and an M.B.A., is the founding President and CEO of BioMS Medical. Prior to this role, Mr. Giese practiced law in Vancouver, has been the past president of Mr. Lube U.S. and was a director and the chief financial officer for NQL Drilling Tools (a TSX listed oilfield equipment company). Mr. Giese became a member BioAlberta?s Board of Directors in October 2006.

Organization Position Status
BioMS Medical Corp. CEO Current
Invest Bioms Medical President & CEO Current
Bioalberta President and CEO of Bioms Medical Current
BioMS Medical Corp. President Current
Bioalberta Board of Directors Current
BioMS Medical Corp. Board of Directors Current
NQL Drilling Tools, Inc. Chief Financial Officer Former

Organization Position Status
BioMS Medical Corp. CFO Current

Organization Position Status
BioMS Medical Corp. COO Current
BioMS Medical Corp. Board of Directors Current

Organization Position Status
BioMS Medical Corp. Executive Vice President Corporate Affairs Current

Organization Position Status
BioMS Medical Corp. Vice President, Clinical Affairs Current

Organization Position Status
BioMS Medical Corp. Vice President, Biostatistics Current

Organization Position Status
BioMS Medical Corp. Vice President, Scientific Affairs Current

Organization Position Status
BioMS Medical Corp. Vice President, Regulatory Affairs Current

Organization Position Status
BioMS Medical Corp. Vice President, Commercial Dev Current

Organization Position Status
BioMS Medical Corp. Vice President, Corp Comm Current
BioMS Medical Corp. Co-Founder Former
Northern Alberta Institute of Technology Former

Organization Position Status
BioMS Medical Corp. Vice President, Drug Dev Current

Organization Position Status
BioMS Medical Corp. Lead Director Current
BioMS Medical Corp. Board of Directors Current

Organization Position Status
BioMS Medical Corp. Manager Current

Organization Position Status
BioMS Medical Corp. Bioms Announces Professor Current
BioMS Medical Corp. Professor and Chairman, Department of Neurology at Heinrich, Heine, Universitat Dusseldorf In Germany Current

Dr. Leonard (Len) I. Wiebe, BSP, MSc is Professor of Radiopharmaceutical Chemistry, in Pharmacy, at the University of Alberta. He holds secondary appointments, as Adjunct Professor in Experimental Oncology (Faculty of Medicine and Dentistry, U. Alberta), Research Associate (Oncological Imaging; Cross Cancer Institute, Edmonton), and Honorary Liaison Professor (People's University of Bangladesh). He is an Editor of Applied Radiation and Isotopes, and J Pharmacy & Pharmaceutical Sciences. During his academic career at the University of Alberta, Professor Wiebe served as Assistant (1985-1988) and Associate Dean (1990-1999) of Graduate Studies and Research (Pharmacy), Founding Director of the Noujaim Institute for Pharmaceutical Oncology Research (1994-1999), Chair of the U. Alberta SLOWPOKE Reactor Committee (1974-1989), and Director of the SLOWPOKE Nuclear Reactor Facility (1977-1989). He was Director of Biomedicine and Health, Australian Nuclear Science and Technology Organization (Ansto) (Sydney, Australia) in 1990.

Organization Position Status
The Isotopes Editor Current
BioMS Medical Corp. Current
Bio-Medicine Director Former

Organization Position Status
BioMS Medical Corp. Current
The Journal of Immunology Associate Editor Former

Organization Position Status
BioMS Medical Corp. Secretary Current

Organization Position Status
Mr. Lube Founder Current
BioMS Medical Corp. Chairman of the Board Current
Mr. Lube Board of Directors Current
NQL Drilling Tools, Inc. Director Former

Organization Position Status
BioMS Medical Corp. Board of Directors Current

Organization Position Status
BioMS Medical Corp. Board of Directors Current

Organization Position Status
BioMS Medical Corp. Board of Directors Current
Novation Pharmaceuticals Inc Board of Directors Current
Biomira Inc. CEO Former
Biomira Inc. President Former
University of Saskatchewan Former

Organization Position Status
BioMS Medical Corp. Board of Directors Current

Organization Position Status
Pillsbury Madison & Sutro Partner Current
Pillsbury Madison & Sutro Co-Leader Current
BioMS Medical Corp. Board of Directors Current
Climate Change Board of Directors Current
University of Florida Ph.D. Degree In Microbiology, Immunology Former
Seton Hall University School of Law J.D. Degree Former
University of Florida B.S. Degree In Chemistry Former
Seton Hall University School of Law B.S. Degree In Chemistry Former

Dr. Warren is currently Professor of Medicine (Neurology) at the University of Alberta, and Director of the Multiple Sclerosis Patient Care and Research Clinic, Department of Medicine. He graduated with a Bachelor degree from the University of Western Ontario in 1968. He received his M.D. (Magna cum Laude) in 1972, and became a Fellow of the Royal College of Physicians and Surgeons (Canada) in 1976. Dr. Warren has been listed among the Best Physicians of North America on both the Who's Who of North America and International Who's Who for Professionals lists. He is credited with several medical discoveries related to herpes simplex virus and multiple sclerosis. In particular, Dr. Warren made several discoveries specific to the myelin basic protein (MBP) and the inhibition of anti-myelin basic protein in cerebrospinal fluid of people with chronic progressive multiple sclerosis. Dr. Warren's work on the development and administration of selected human MBP synthetic peptides to neutralize the progress of multiple sclerosis has been presented and published for world-wide audiences of researchers, medical professionals and people with multiple sclerosis. He is co-inventor of MBP8298.

Organization Position Status
University of Alberta Professor of Medicine Current
BioMS Medical Corp. Board of Directors Current

Organization Position Status
Invest Bioms Medical Director Current
BioMS Medical Corp. Director Current
University of Alberta Degrees In Pharmacy and Law Former

Organization Position Status
BioMS Medical Corp. Board of Directors Current

Organization Position Status
BioMS Medical Corp. Board of Directors Current

Organization Position Status
BioMS Medical Corp. Board of Directors Current

Executive News

  • BioMS Terminates License Deal For Multiple Sclerosis Drug Candidate With Eli Lilly - Quick Facts

    RTTNews.com - 9/02/09 - View Story

  • BioMS Medical Provides Update on Dirucotide

    CNW Group via Yahoo! - 9/02/09 - View Story

advertisement
Click Here
MS $32.12 -0.50 (-1.53% )
Volume 9,689,367
Shares Outstanding 1.3B
Market Cap 43.6B
Year High 35.78
Year Low 10.61
Earnings Per Share 0.11
P/E Ratio 292.00
Dividend 0.20
Yield 0.622665
IndustryTop Rated
advertisement